Lv1
90 积分 2025-08-15 加入
Regulation of Glutathione Peroxidases (GPxs) in Breast Cancer: From Mechanisms to Targeted Therapeutics
5小时前
待确认
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
6天前
已完结
Ferroptosis and its role in immune modulation in breast cancer
2个月前
已完结
In situ delivery of JPH203 via camptothecin-peptide conjugate nanoassemblies to trigger ferroptosis in triple-negative breast cancer
2个月前
已完结
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
5个月前
已完结
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy
5个月前
已完结
Antibody–Drug Conjugates: A Comprehensive Review
5个月前
已完结
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
7个月前
已完结
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial
7个月前
已完结
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
7个月前
已完结
皖公网安备34019202002308
